S-Network Medical Breakthroughs Index

An index of small and mid-cap biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.

As January 30, 2024 Index Level 3-Month 6-Month 1-Year YTD
Price Return 7,502.7 38.5% 5.5% 4.9% 1.1%
Total Return 7,978.3 38.5% 5.5% 4.9% 1.1%
Net Total Return 7,962.1 38.5% 5.5% 4.9% 1.1%
Index Level 7,502.7
3-Month 38.5%
6-Month 5.5%
1-Year 4.9%
YTD 1.1%
Index Level 7,978.3
3-Month 38.5%
6-Month 5.5%
1-Year 4.9%
YTD 1.1%
Index Level 7,962.1
3-Month 38.5%
6-Month 5.5%
1-Year 4.9%
YTD 1.1%

As of January 30, 2024

Characteristics

Index Symbol (Price Return) PMBI
Index Symbol (Total Return) PMBITR
Index Symbol (Net Total Return) PMBINT
Number of Constituents 93
Market Capitalization $151 Billion
Adjusted Market Capitalization $115 Million
Rebalancings Quarterly
Dividend Yield 0.00%

Composition

Top Index Constituents
As of April 12, 2024

Interested in Market Data packages?

VettaFi's indexes are widely used by financial firms, industry stakeholders and professionals to support a variety of business functions. We offers a range of end-of-day and historical index data subscriptions.

Contact Us